U.S. Hospitality Stock News

Polestar Automotive Holding UK (PSNY) has amended its term facility with affiliate Geely Sweden Automotive Investment AB, extending the loan maturity to June 30, 2027, and lifting the margin from 3.0% to 3.2%. See our latest analysis for Polestar Automotive Holding UK. The extended facility comes as Polestar’s share price has been volatile, with a 7 day share price return down 18.11%, a 90 day share price return up 14.13%, and a 1 year total shareholder return down 38.24%. This suggests that...

If you are wondering whether Garmin at around US$236.57 is offering good value right now or if the strong run is already priced in, this breakdown will help you frame that question clearly. The stock is up 1.1% over the last 7 days, slightly down 2.6% over the last month, and has returns of 16.9% year to date, 15.9% over 1 year, 137.7% over 3 years, and 81.9% over 5 years, giving you a wide range of recent performance to consider. Recent coverage has focused on Garmin's position in consumer...

Wondering if Figma at around US$21.75 a share is a bargain or a value trap? This article walks through what the current price is really telling you about the stock. The stock has been volatile recently, with the share price down 14.7% over the past week but up 12.8% over the last 30 days, and it remains down 42.2% year to date. Recent headlines have focused on Figma's position in the broader software sector and ongoing interest in collaboration tools, which helps frame how investors are...

SailPoint (NasdaqGS:SAIL) reports crossing US$1b in Annual Recurring Revenue. The company highlights rapid growth in SaaS ARR and AI driven identity security offerings. SailPoint launches new AI focused products and integrates with leading AI compliance APIs. SailPoint focuses on identity security, helping enterprises control who has access to which systems and data. As companies shift more workloads to the cloud and adopt AI tools, identity and access controls are becoming central to...

Wondering if UL Solutions at around US$96.81 is priced for opportunity or already fully valued? This article walks through what the market might be implying about the stock. The share price has risen 19.7% year to date and 36.9% over the past year, even though it has fallen 2.7% in the last week and 7.7% over the last month. Recent coverage has focused on UL Solutions as part of broader discussions about professional services stocks and how investors are reassessing quality and growth...

X-energy, Inc. recently submitted its Xe-100 high-temperature gas-cooled reactor design to enter the United Kingdom’s Generic Design Assessment process, a key step in securing UK regulatory approval for future deployment. This move deepens X-energy’s collaboration with Centrica on up to 6 GW of advanced nuclear capacity and leverages cross-border regulatory cooperation with U.S. authorities to potentially streamline licensing. We’ll now examine how this progress on UK licensing, especially...

AGNC Investment (NasdaqGS:AGNC) has approved a new $1b stock repurchase plan running through 2026. The company is actively repositioning its portfolio toward higher coupon agency MBS and stronger interest rate hedging. This follows earlier capital raising activity and marks a shift in how AGNC is choosing to deploy capital. AGNC Investment, trading at around $10.17 per share, enters this new phase after a mixed stretch for the stock, with the share price up 28.3% over the past year but down...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Before deciding whether Align Technology stock looks attractive or not, you probably want to know if the current price around US$167.74 fairly reflects what the business might be worth. Over the short term, the stock has been under pressure, with the share price down 4.1% over the last week and 3.6% over the last month, although it is up 7.5% year to date. The one year and three year returns show declines of 7.1% and 44.9% respectively, with a 72.6% decline over five years. Recent news...

Innospec (NasdaqGS:IOSP) has appointed Shelley Bausch to its Board of Directors. Bausch will also serve on the Audit Committee, expanding the committee's membership. For investors watching Innospec, the boardroom is just as important as the income statement. The stock trades at $80.68, with the share price up 3.9% over the past 30 days and up 5.8% year to date, while the value score stands at 6. Over 1 year, 3 years, and 5 years, the share price is down 4.1%, 14.9%, and 11.5% respectively,...

Crypto and blockchain are no longer just about tokens and trading. They sit at the crossroads of payments, data security and new ways of building financial services, all while global markets keep a close eye on inflation, interest rates and liquidity. With consumer demand holding up, central banks adjusting policy and digital assets staying in the spotlight, many investors are looking for listed companies that are directly involved in this space. This article highlights 3 stocks from the Top...

Kemper Corporation (NYSE:KMPR) has appointed Stephen J. McAnena as President and CEO. Anthony J. DeSantis has joined Kemper’s Board of Directors. These leadership changes represent a refresh at the top of the organization that could influence future direction. Kemper operates in the insurance sector, where leadership decisions can affect underwriting priorities, product mix, and capital allocation. For shareholders, the arrival of a new CEO and an additional board member often prompts a...

Why KULR’s new drone battery contract matters for investors KULR Technology Group (KULR) has signed a prototype development and fabrication agreement with a U.S. defense drone manufacturer, putting its lithium ion battery technology directly into unmanned aerial vehicle and controller programs. Under this contract, KULR is responsible for system level battery design, architecture, prototyping, testing, certification support, and production readiness for the customer’s UAVs and ground control...

HCA Healthcare (NYSE:HCA) is acquiring 17 urgent care clinics across the Carolinas under its CareNow brand, marking its entry into the South Carolina urgent care market. The company has reached a network agreement with Cigna that maintains in network access for Cigna-insured patients at HCA facilities after a period of contract uncertainty. HCA is expanding into healthcare education through the acquisition of the College of Health Care Professions, adding an education arm to its existing...

If you are wondering whether Skyworks Solutions at around US$73.57 is pricing in too much hope or not enough, the starting point is to understand what the current valuation actually reflects. The stock is up 14.2% year to date and 13.2% over the last month, but is still down 21.9% over three years and 50.3% over five years. These different time frames can leave current holders and new investors reading those moves in very different ways. Recent headlines have focused on the stock's role as a...

Recent performance context CNO Financial Group (CNO) has drawn investor attention after recent trading, with the stock last closing at $47.91 and showing gains over the past week, month, and past 3 months. See our latest analysis for CNO Financial Group. That recent 1-day share price return of 1.68% sits within a broader trend, with a 90-day share price return of 15.33% and a 1-year total shareholder return of 26.21%, suggesting momentum has been building over time. If CNO's recent move has...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Limbach Holdings, Inc. recently participated in Stifel's Ninth Annual Boston Cross Sector 1x1 Conference at The InterContinental Boston, where President, CEO and Director Michael M. McCann presented the company’s story to investors. This investor-facing appearance offered management a platform to discuss Limbach’s evolving business mix, including its focus on higher-margin service relationships and energy-efficient building solutions. We’ll now look at how McCann’s conference appearance and...

In late May 2026, Privia Health Group, Inc. signed a definitive agreement to enter the New Jersey market by partnering with the Neurology Group of Bergen County, a 25-clinician adult and pediatric neurology practice that will anchor Privia Medical Group, New Jersey and is expected to be on the Privia platform by year-end 2026. This partnership gives Privia a foothold in a new state while extending its interoperable technology and population health capabilities to community neurologists and...

In May 2026, Icahn Enterprises L.P. reported first-quarter 2026 results showing revenues of US$2.20 billion, a GAAP net loss of US$459 million, and a US$201 million increase in Indicative Net Asset Value largely tied to gains in its CVI position. The Board also declared a quarterly distribution of US$0.50 per depositary unit, payable in cash or additional units, highlighting management’s continued emphasis on returning capital to unitholders despite reported losses. Next, we’ll consider how...

In recent days, Provident Financial Services has benefited from a broader regional bank rally amid a stable, higher-for-longer interest rate backdrop that is supporting sector-wide net interest margins. Separately, Provident Bank’s appointment of Annamaria Vitelli as Executive Vice President, Chief Wealth Officer and President of Beacon Trust highlights a renewed push to grow its wealth management and fiduciary services franchise. We'll now examine how the sector-wide rate backdrop and...

If you are wondering whether DexCom at around US$72.86 is a bargain or a stock to be cautious about, the next step is to look closely at what that price might already be pricing in. The stock has risen 20.7% over the past month and is up 9.5% year to date, even though it is down 1.2% over the past week and has declined 15.9% over the last year and 41.4% over three years. Recent headlines around glucose monitoring, reimbursement policies and competition in medical devices help explain why...